FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Glenmark Pharmaceuticals Saxagliptin Tablets 5mg Recall

Saxagliptin Tablets 5mg, a)

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class II
Reported by FDA
Apr 16, 2025
Recall ID
D-0332-2025
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Saxagliptin Tablets 5mg starting Mar 13, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0332-2025 on Apr 16, 2025. Reason: CGMP Deviations. Status: Ongoing.

Why it was recalled

CGMP Deviations

Product description

Saxagliptin Tablets 5mg, a). 30-count bottle (NDC# 68462-727-30) b.) 90-count bottle ( 68462-727-90), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.

Lot numbers, UPCs & expiration codes

Lot # 17232460, exp. date Nov-25 17232460, exp. date Nov-25 17241194, exp. date Jun-26 17241194, exp. date Jun-26

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0332-2025
Classification
Class II
Status
Ongoing
Recall initiated
Mar 13, 2025
FDA report date
Apr 16, 2025
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0332-2025, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Ongoing
Country
United States
Event ID
96474
Address
750 Corporate Dr
Code information
Lot # 17232460, exp. date Nov-25 17232460, exp. date Nov-25 17241194, exp. date Jun-26 17241194, exp. date Jun-26
Postal code
07430-2009
Report date
Apr 16, 2025
Product type
Drugs
Recall number
D-0332-2025
Classification
Class II
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Saxagliptin Tablets 5mg, a). 30-count bottle (NDC# 68462-727-30) b.) 90-count bottle ( 68462-727-90), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.
Distribution pattern
U.S. Nationwide
Recall initiation date
Mar 13, 2025
Initial firm notification
Letter
Center classification date
Apr 8, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0332-2025, published Apr 16, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls